Sun Pharma Advanced Research Company Ltd (SPARC) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 739743,
    "name": "SPARC",
    "stock_name": "SPARC",
    "full_name": "Sun Pharma Advanced Research Company Ltd",
    "name_url": "stocks-analysis/sparc",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "242.05",
    "chg": 2.65,
    "chgp": "1.11%",
    "dir": 1,
    "prev_price": "239.40",
    "mcapval": "7,855.05 Cr",
    "mcap": "Small Cap",
    "scripcode": 532872,
    "symbol": "SPARC",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE232I01014",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "64.62 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/sparc-739743-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Sun Pharma Advanced Research Company Ltd: Valuation Shift Signals Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharma-advanced-research-company-ltd-valuation-shift-signals-renewed-price-attractiveness-4002052",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SunPharmaAdvanc_valuationdot_4002052.png",
        "date": "2026-05-21 08:00:57",
        "description": "Sun Pharma Advanced Research Company Ltd (SPARC) has witnessed a significant transformation in its valuation parameters, moving from a previously risky profile to one that no longer qualifies as such. This shift, marked by a sharp decline in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios, alongside robust return metrics, has altered the stock’s price attractiveness in the Pharmaceuticals & Biotechnology sector. Investors are now re-evaluating SPARC’s potential amid a backdrop of strong operational performance and favourable market returns."
      },
      {
        "title": "Sun Pharma Advanced Research Company Ltd Upgrades Quality Grade Amid Improving Fundamentals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharma-advanced-research-company-ltd-upgrades-quality-grade-amid-improving-fundamentals-4001968",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SunPharmaAdvanc_qualitydot_4001968.png",
        "date": "2026-05-21 08:00:12",
        "description": "Sun Pharma Advanced Research Company Ltd (SPARC) has witnessed a notable upgrade in its quality grading from below average to good, reflecting significant improvements in its business fundamentals. This shift comes amid a backdrop of strong sales and earnings growth, reduced debt levels, and enhanced return metrics, positioning the company more favourably within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Are Sun Pharma Advanced Research Company Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-sun-pharma-advanced-research-company-ltd-latest-results-good-or-bad-4001465",
        "imagepath": "",
        "date": "2026-05-20 19:20:25",
        "description": "The latest financial results for Sun Pharma Advanced Research Company Ltd (SPARC) reveal a significant and unusual quarter, particularly for Q4 FY26. The company reported net sales of ₹1,853.22 crores, reflecting an extraordinary quarter-on-quarter growth of 21,831.60% compared to the previous quarter's sales of ₹8.45 crores. This surge in revenue is attributed to a one-time event, likely involving intellectual property licensing or milestone payments, rather than sustainable operational performance.\n\nIn terms of profitability, SPARC reported a net profit of ₹1,761.34 crores for the same quarter, which marks a dramatic turnaround from the losses experienced in prior quarters. However, this profit is also heavily influenced by the aforementioned one-time gain, raising concerns about the sustainability of such earnings. The company's operating margin and PAT margin reached exceptionally high levels of 13,433...."
      },
      {
        "title": "Sun Pharma Advanced Research Company Ltd Reports Remarkable Quarterly Turnaround Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharma-advanced-research-company-ltd-reports-remarkable-quarterly-turnaround-amid-market-challenges-3999006",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SunPharmaAdvanc_fintrenddot_3999006.png",
        "date": "2026-05-19 11:00:13",
        "description": "Sun Pharma Advanced Research Company Ltd (SPARC) has delivered a striking reversal in its financial trajectory for the quarter ended March 2026, posting record revenues and profitability that sharply contrast with its recent negative trend. This turnaround comes amid a challenging market environment and follows a significant upgrade in the company’s financial trend score, signalling renewed investor interest despite lingering concerns over its longer-term performance."
      },
      {
        "title": "Sun Pharma Advanced Research Company Ltd Surges 8.2% to Day's High of Rs 175.5 — Outperforms Sector by 6.24 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharma-advanced-research-company-ltd-hits-intraday-high-with-82-surge-3998972",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SunPharmaAdvanc_priceRelatedfactors_3998972.png",
        "date": "2026-05-19 10:31:03",
        "description": "The Sensex climbed 0.45% on 19 May 2026, yet Sun Pharma Advanced Research Company Ltd outpaced the broader market with an 8.2% gain, reaching an intraday high of Rs 175.5. This 6.24 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector signals a distinctly stock-specific rally rather than a market-wide lift."
      },
      {
        "title": "Sun Pharma Advanced Research Company Ltd Opens 8.02% Higher Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharma-advanced-research-company-ltd-opens-with-strong-gap-up-reflecting-positive-market-momentum-3998591",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SunPharmaAdvanc_gapup_3998591.png",
        "date": "2026-05-19 09:50:18",
        "description": ""
      },
      {
        "title": "Golden Cross Confirmed: Do Sun Pharma Advanced Research Company Ltd's Other Technical Indicators Agree?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharma-advanced-research-company-ltd-forms-golden-cross-signalling-potential-bullish-breakout-3997463",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SunPharmaAdvanc_goldencross_3997463.png",
        "date": "2026-05-18 18:00:30",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Sun Pharma Advanced Research Company Ltd, signalling a golden cross on 18 May 2026. Yet, the stock declined 0.89% on the day this crossover occurred, and the monthly technical indicators present a more nuanced picture. This divergence between the moving averages and other signals invites a closer examination of the reliability of this technical event."
      },
      {
        "title": "When is the next results date for Sun Pharma Advanced Research Company Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-sun-pharma-advanced-research-company-ltd-3988150",
        "imagepath": "",
        "date": "2026-05-12 23:16:53",
        "description": "The next results date for Sun Pharma Advanced Research Company Ltd is scheduled for 18 May 2026...."
      },
      {
        "title": "Sun Pharma Advanced Research Company Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sun-pharma-advanced-research-company-ltd-is-rated-strong-sell-3987285",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SunPharmaAdvanc_mojoScore_3987285.png",
        "date": "2026-05-12 10:10:46",
        "description": "Sun Pharma Advanced Research Company Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 Feb 2024. However, the analysis and financial metrics presented here reflect the stock’s current position as of 12 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 15,
    "sid": "739743",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/sun-pharma-advanced-research-company-739743"
  },
  "announcements": [
    {
      "caption": "Statutory Auditors Certificate In Terms Of Regulation 169(5) Of SEBI ICDRA Regulations 2018",
      "datetime": "25-May-2026",
      "details": "Statutory Auditors Certificate in terms of Regulation 169(5) of SEBI ICDRA Regualations 2018",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "20-May-2026",
      "details": "Newspaper Advertisement for Publication of Financials",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "20-May-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shanghvi Finance Pvt Ltd & PACs",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharma Advanced Research Company Ltd has announced <strong>5:116</strong> rights issue, ex-date: 16 Mar 16",
          "dt": "2016-03-16",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Sun Pharma Advanced Research Company Ltd: Valuation Shift Signals Renewed Price Attractiveness

2026-05-21 08:00:57

Sun Pharma Advanced Research Company Ltd (SPARC) has witnessed a significant transformation in its valuation parameters, moving from a previously risky profile to one that no longer qualifies as such. This shift, marked by a sharp decline in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios, alongside robust return metrics, has altered the stock’s price attractiveness in the Pharmaceuticals & Biotechnology sector. Investors are now re-evaluating SPARC’s potential amid a backdrop of strong operational performance and favourable market returns.

Sun Pharma Advanced Research Company Ltd Upgrades Quality Grade Amid Improving Fundamentals

2026-05-21 08:00:12

Sun Pharma Advanced Research Company Ltd (SPARC) has witnessed a notable upgrade in its quality grading from below average to good, reflecting significant improvements in its business fundamentals. This shift comes amid a backdrop of strong sales and earnings growth, reduced debt levels, and enhanced return metrics, positioning the company more favourably within the Pharmaceuticals & Biotechnology sector.

Are Sun Pharma Advanced Research Company Ltd latest results good or bad?

2026-05-20 19:20:25

The latest financial results for Sun Pharma Advanced Research Company Ltd (SPARC) reveal a significant and unusual quarter, particularly for Q4 FY26. The company reported net sales of ₹1,853.22 crores, reflecting an extraordinary quarter-on-quarter growth of 21,831.60% compared to the previous quarter's sales of ₹8.45 crores. This surge in revenue is attributed to a one-time event, likely involving intellectual property licensing or milestone payments, rather than sustainable operational performance. In terms of profitability, SPARC reported a net profit of ₹1,761.34 crores for the same quarter, which marks a dramatic turnaround from the losses experienced in prior quarters. However, this profit is also heavily influenced by the aforementioned one-time gain, raising concerns about the sustainability of such earnings. The company's operating margin and PAT margin reached exceptionally high levels of 13,433....

Sun Pharma Advanced Research Company Ltd Reports Remarkable Quarterly Turnaround Amid Market Challenges

2026-05-19 11:00:13

Sun Pharma Advanced Research Company Ltd (SPARC) has delivered a striking reversal in its financial trajectory for the quarter ended March 2026, posting record revenues and profitability that sharply contrast with its recent negative trend. This turnaround comes amid a challenging market environment and follows a significant upgrade in the company’s financial trend score, signalling renewed investor interest despite lingering concerns over its longer-term performance.

Sun Pharma Advanced Research Company Ltd Surges 8.2% to Day's High of Rs 175.5 — Outperforms Sector by 6.24 Percentage Points

2026-05-19 10:31:03

The Sensex climbed 0.45% on 19 May 2026, yet Sun Pharma Advanced Research Company Ltd outpaced the broader market with an 8.2% gain, reaching an intraday high of Rs 175.5. This 6.24 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector signals a distinctly stock-specific rally rather than a market-wide lift.

Sun Pharma Advanced Research Company Ltd Opens 8.02% Higher Amid Mixed Technical Signals

2026-05-19 09:50:18

Golden Cross Confirmed: Do Sun Pharma Advanced Research Company Ltd's Other Technical Indicators Agree?

2026-05-18 18:00:30

The 50-day moving average has crossed above the 200-day moving average for Sun Pharma Advanced Research Company Ltd, signalling a golden cross on 18 May 2026. Yet, the stock declined 0.89% on the day this crossover occurred, and the monthly technical indicators present a more nuanced picture. This divergence between the moving averages and other signals invites a closer examination of the reliability of this technical event.

When is the next results date for Sun Pharma Advanced Research Company Ltd?

2026-05-12 23:16:53

The next results date for Sun Pharma Advanced Research Company Ltd is scheduled for 18 May 2026....

Sun Pharma Advanced Research Company Ltd is Rated Strong Sell

2026-05-12 10:10:46

Sun Pharma Advanced Research Company Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 Feb 2024. However, the analysis and financial metrics presented here reflect the stock’s current position as of 12 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

View All News